Asian Surveying & Mapping
Breaking News
Synspective Succeeds in Acquiring Japan’s Highest Resolution 25cm SAR image
TOKYO, 2024 – Synspective Inc., a provider of Synthetic...
Why Indian-origin astronaut Sunita Williams is stuck in space
The Starliner mission is seen as a landmark for...
China Successfully Launches Tianhui 5-02 Remote Sensing Satellite
China has successfully launched the Tianhui 5-02 Earth remote...
ISRO to organise hackathon to celebrate first National Space Day on Aug 23
BENGALURU: For the first National Space Day, which will...
Japan launches Earth observation satellite on new flagship H3 rocket
TOKYO, Japan: Japan successfully launched an upgraded Earth observation...
China fortifies Tiangong space station after Russian satellite explosion
Two Shenzhou-18 astronauts completed a spacewalk on Wednesday night to...
Unveiling East Asia’s urban landscape: A massive mapping project illuminates 280 million buildings
Accurate and comprehensive building data is critical for urban...
Japan successfully launches an advanced Earth observation satellite on its new flagship H3 rocket
Japan has successfully deployed an upgraded Earth observation satellite...
Synspective Secures 7 Billion Yen in Series C Funding
TOKYO, 2024, June 20th – Synspective Inc., a Synthetic...
South Korea launches its own NASA
Determined to join the ranks of global space powers,...

June 29th, 2020
Topcon Announces the European Launch of MYAH

CAPELLE A/D IJSSEL, Netherlands – Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has launched its new MYAH instrument to the European region. MYAH is a comprehensive management tool for eyecare professionals interested in building, managing and growing myopia and dry eye services within their practice or research institution.

The versatile, all-in-one MYAH provides all the critical tools needed to support myopia management while also offering an evolving platform to add or grow dry eye management. MYAH incorporates corneal topography including keratoconus screening and pupillometry, axial length measurements by optical low coherence interferometry, progression reports for analyzing treatment efficacy, and a comprehensive suite of dry eye assessment tools. The instrument is compact, easy to operate, and offers rapid capture to ensure patient satisfaction.

With the launch of MYAH, Topcon achieves a milestone in the battle against the global myopia epidemic. It is estimated that 50% of the world’s population, including European regions, may be myopic by 20501.

“MYAH is ideally suited to combat the growing crises of both myopia and dry eye disease. Its versatility and ease of use allows eyecare professionals to easily build a myopia service within their practice, educate patients on the implications of myopia and dry eye disease, manage their patients’ conditions, and grow their service offerings,” stated John Trefethen, Global VP of Marketing & Product Design for Topcon Healthcare.

For more information on MYAH, please visit www.topconmyah.com.

About Topcon Healthcare

Topcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever-changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management and ground-breaking remote diagnostic technology.

A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.

  1. Holden, BA, Fricke, TR, Wilson, DA et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016; 123:1036–42. Available from: doi: DOI: 10.1016/j.ophtha.2016.01.006